GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Liabilities-to-Assets

HTDS (Hard to Treat Diseases) Liabilities-to-Assets : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Hard to Treat Diseases's Total Liabilities for the quarter that ended in . 20 was $0.00 Mil. Hard to Treat Diseases's Total Assets for the quarter that ended in . 20 was $0.00 Mil.


Hard to Treat Diseases Liabilities-to-Assets Historical Data

The historical data trend for Hard to Treat Diseases's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Liabilities-to-Assets Chart

Hard to Treat Diseases Annual Data
Trend
Liabilities-to-Assets

Hard to Treat Diseases Quarterly Data
Liabilities-to-Assets

Competitive Comparison of Hard to Treat Diseases's Liabilities-to-Assets

For the Biotechnology subindustry, Hard to Treat Diseases's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hard to Treat Diseases's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Liabilities-to-Assets falls into.



Hard to Treat Diseases Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Hard to Treat Diseases's Liabilities-to-Assets Ratio for the fiscal year that ended in . 20 is calculated as:

Liabilities-to-Assets (A: . 20 )=Total Liabilities/Total Assets
=/
=N/A

Hard to Treat Diseases's Liabilities-to-Assets Ratio for the quarter that ended in . 20 is calculated as

Liabilities-to-Assets (Q: . 20 )=Total Liabilities/Total Assets
=/
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hard to Treat Diseases  (OTCPK:HTDS) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Hard to Treat Diseases Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hard to Treat Diseases Business Description

Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases Headlines

No Headlines